
肺结核治疗中利奈唑胺相关血小板减少的时序特征、风险评估及临床决策
Linezolid-associated thrombocytopenia in pulmonary tuberculosis treatment: temporal characteristics, risk assessment, and clinical decision-making
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |